医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Walgreens Boots Alliance Commits $350,000 to Help Address Critical COVID-19 Needs in India

2021年05月08日 AM01:14
このエントリーをはてなブックマークに追加


 

DEERFIELD, Ill.

To help address the critical need for COVID-19-related resources during a surge in cases and deaths in India, Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced a commitment of US$350,000 to the American India Foundation (AIF).

For a total of $350,000 or more, WBA will:

  • provide a direct donation of $100,000
  • allow its team members to donate to a special fund, amounting to at least $100,000
  • match these contributions from team members, up to $100,000
  • contribute an in-kind product donation of approximately $50,000 worth of pulse oximeters

Pulse oximeters are non-invasive devices that measure oxygen saturation. AIF will distribute them to rural healthcare workers on the frontlines across India.

“Throughout the pandemic, WBA has been committed to keeping communities safe and providing much-needed healthcare services, while also working to address barriers to access,” said Rosalind Brewer, CEO, Walgreens Boots Alliance. “Our thoughts are with everyone in India right now, and we are proud to support the American India Foundation to deliver immediate and vital resources at this critical time.”

The contributions to AIF build on WBA’s extensive response efforts throughout the pandemic in thousands of communities around the world, including providing access to COVID-19 testing across more than 6,000 Walgreens and Boots stores, administering more than 15 million COVID-19 vaccines and continually offering the latest health information and resources.

Notes to Editors:

About Walgreens Boots Alliance

Walgreens Boots Alliance (Nasdaq: WBA) is a global leader in retail and wholesale pharmacy, touching millions of lives every day through dispensing and distributing medicines, and through its convenient retail locations, digital platforms and health and beauty products. The company has more than 100 years of trusted health care heritage and innovation in community pharmacy and pharmaceutical wholesaling.

Including equity method investments, WBA has a presence in more than 25 countries, employs more than 450,000 people and has more than 21,000 stores.

WBA’s purpose is to help people across the world lead healthier and happier lives. The company is proud of its contributions to healthy communities, a healthy planet, an inclusive workplace and a sustainable marketplace. WBA is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business.

WBA is included in FORTUNE’s 2021 list of the World’s Most Admired Companies*. This is the 28th consecutive year that WBA or its predecessor company, Walgreen Co., has been named to the list.

More company information is available at www.walgreensbootsalliance.com.

*© 2021, Fortune Media IP Limited. Used under license.

(WBA-GEN)

Cautionary Note Regarding Forward-Looking Statements: All statements in this release that are not historical are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are not guarantees of future performance and involve risks, assumptions and uncertainties, including those described in Item 1A (Risk Factors) of our Form 10-K for the fiscal year ended Aug. 31, 2020, our Quarterly Report on Form 10-Q for the fiscal quarter ended Nov. 30, 2020 and in other documents that we file or furnish with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially. These forward-looking statements speak only as of the date they are made. We do not undertake, and expressly disclaim, any duty or obligation to update publicly any forward-looking statement after the date of this release, whether as a result of new information, future events, changes in assumptions or otherwise.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210507005458/en/

CONTACT

Media Relations

USA / Jim Cohn +1 224 813 9057

International +44 (0)20 7980 8585

Investor Relations

Gerald Gradwell and Jay Spitzer +1 847 315 2922

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Arcturus Therapeutics Announces Meeting with President of Vietnam and CEO of Vingroup to Discuss Expansion of COVID-19 Vaccine Collaboration
  • DKT International Implements Traditional and New Forms of Marketing in Africa, South America, and Southeast Asia to Expand Access to Contraceptives
  • オルガノンが計画外妊娠をめぐり世界規模の対話の喚起を目指す
  • IHMA Opens Microbiology Reference Laboratory in Shanghai, China to Further Support Global Anti-Infective Product Discovery and Development
  • Cyclica and IMPACT Therapeutics Team Up to Advance Differentiated Anti-cancer Drug Development